University of Texas at Austin: First Digital Platform to Track and Prevent Drug Overdoses in Texas Launches

University of Texas at Austin: First Digital Platform to Track and Prevent Drug Overdoses in Texas Launches. “The rate of opioid and other drug overdoses is on the rise in Texas, but there has been no statewide system to collect overdose data—until now. An interdisciplinary team of developers, designers, clinical partners and researchers led by Dell Medical School and the Steve Hicks School of Social Work at The University of Texas at Austin has created a digital reporting and surveillance system to track drug overdoses statewide.”

Jerusalem Post: Israeli drug for severe COVID reduces death by 70% – phase 2 trial

Jerusalem Post: Israeli drug for severe COVID reduces death by 70% – phase 2 trial. “Bonus BioGroup released new data this week showing that the 30-days survival rate of 50 severely ill hospitalized patients with oxygen saturation of 93% and below and diffuse pneumonia who received up to three doses of the company’s MesenCure treatment was 94% – meaning 47 out of 50 patients survived.”

Newswise: COVID patients on SSRI antidepressants are less likely to die, UCSF-Stanford study finds

Newswise: COVID patients on SSRI antidepressants are less likely to die, UCSF-Stanford study finds. ” A large analysis of health records from 87 health care centers across the United States found that people taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), particularly fluoxetine, were significantly less likely to die of COVID-19 than a matched control group. The results add to a body of evidence indicating that SSRIs may have beneficial effects against the worst symptoms of COVID-19, although large randomized clinical trials are needed to prove this.”

BBC: First pill to treat Covid gets approval in UK

BBC: First pill to treat Covid gets approval in UK. “The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator. The tablet – molnupiravir – will be given twice a day to vulnerable patients recently diagnosed with the disease. In clinical trials the pill, originally developed to treat flu, cut the risk of hospitalisation or death by about half.”

Washington Post: Merck’s experimental pill to treat covid-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports

Washington Post: Merck’s experimental pill to treat covid-19 cuts risk of hospitalization and death in half, the pharmaceutical company reports. “Merck announced Friday that an experimental pill it developed to treat covid-19 reduced the risk of hospitalization and death by nearly half in a clinical trial. An independent board of experts monitoring the trial recommended the study be stopped early because of the positive results, a significant and telling step in a pharmaceutical study. Merck and partner Ridgeback Biotherapeutics said in a news release they would apply for emergency use authorization for the drug, molnupiravir, in the United States as soon as possible. It would be the first antiviral pill for covid-19.”

NewsWise: Medicine that treats gout could also battle COVID-19

NewsWise: Medicine that treats gout could also battle COVID-19. “Published in Nature’s Scientific Reports, the study found that probenecid has broad antiviral properties, making it a prime candidate to combat not only SARS-CoV-2 infection but also other common and deadly respiratory viruses like RSV and flu. Probenecid is an FDA-approved medication that’s primarily used to treat gout, and it’s already widely available in the U.S. The drug has been on the market for over 40 years and has minimal side effects.”

Column: Major study of Ivermectin, the anti-vaccine crowd’s latest COVID drug, finds ‘no effect whatsoever’ (Los Angeles Times)

Los Angeles Times: Column: Major study of Ivermectin, the anti-vaccine crowd’s latest COVID drug, finds ‘no effect whatsoever’. “Ivermectin, the latest supposed treatment for COVID-19 being touted by anti-vaccination groups, had ‘no effect whatsoever’ on the disease, according to a large patient study. That’s the conclusion of the Together Trial, which has subjected several purported nonvaccine treatments for COVID-19 to carefully designed clinical testing. The trial is supervised by McMaster University in Hamilton, Canada, and conducted in Brazil.”

Daily Beast: Pharmacists Fight Off COVID Truthers Demanding Horse Medicine Instead of the Jab

Daily Beast: Pharmacists Fight Off COVID Truthers Demanding Horse Medicine Instead of the Jab. “Devotees have besieged pharmacists with prescriptions from shady online prescribers, forcing pharmacies to crack down and treat the antiparasitic drugs like opioids. As human-approved ivermectin prescriptions have been harder to come by, enthusiasts have taken to raiding rural tractor supply stores in search of ivermectin horse paste (packed with ‘apple flavor!’) and weighed the benefits of taking ivermectin ‘sheep drench’ and a noromectin ‘injection for swine and cattle.’”

PubMed: Accuracy of Google Translate in translating the directions and counseling points for top-selling drugs from English to Arabic, Chinese, and Spanish

PubMed: Accuracy of Google Translate in translating the directions and counseling points for top-selling drugs from English to Arabic, Chinese, and Spanish. “For the top 100 drugs, 38 unique directions for use and 170 unique counseling points were identified for translation. For the 38 directions for use, 29 (76.3%) of the Arabic translations were accurate, 34 (89.5%) of the Chinese (simplified) translations were accurate, and 27 (71%) of the Spanish translations were accurate. For the 170 counseling points, 92 (54.1%) of the Arabic translations were accurate, 130 (76.5%) of the Chinese (simplified) translations were accurate, and 65 (38.2%) of the Spanish translations were accurate. Of the 247 inaccurate translations, 72 (29.1%) were classified as highly clinically significant or potentially life-threatening.”